There are 2867 resources available
1707P - The landscape of PALB2 alteration in Chinese solid tumor patients
Presenter: Zhihua Cui
Session: Poster session 11
1139P - A CT-based radiomic readout on the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors
Presenter: Fariba Tohidinezhad
Session: Poster session 15
866P - Inflammation proteins associated with worse clinical outcome to treatment with anti-PD1 in metastatic cutaneous melanoma
Presenter: Fernanda Costa Svedman
Session: Poster session 03
1708P - SMARCA4/SMARCB1 alterations detected through tissue comprehensive genomic profiling (CGP): A single-center study of prevalence and clinical characteristics
Presenter: Jorge Bartolomé Arcilla
Session: Poster session 11
1140P - A chemo-holiday immunotherapy regimen for advanced NSCLC
Presenter: Feng Li
Session: Poster session 15
867P - The association between polygenic risk of autoimmune disease, progression-free survival (PFS), and pathway-level transcriptomic signatures predictive of anti-PD1 response in melanoma
Presenter: Carina Owen
Session: Poster session 03
1709P - Cascade genetic testing utilized only in 31% of initial families with pathogenic variants in breast cancer genes
Presenter: Dimitrios Ziogas
Session: Poster session 11
1141P - A multicenter study of incidence of drug-induced lung disease in first-line osimertinib therapy and continuation of osimertinib administration
Presenter: Chihiro Mimura
Session: Poster session 15
868P - System biology approach to normal tissue protection in cytotoxic cancer therapy: Experimentally validated gene/signaling basis – melanoma as case study
Presenter: Bindu Kumari
Session: Poster session 03
1710P - Genomic landscape (GL) with potential of methylthioadenosine phosphorylase (MTAP) loss in clinically advanced breast cancer (CABC)
Presenter: Maroun Bou Zerdan
Session: Poster session 11